First Capital Advisors Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$450K Sell
5,110
-303
-6% -$26.1K 0.24% 79
2023
Q1
$436K Buy
5,413
+429
+9% +$35K 0.28% 78
2022
Q4
$387K Sell
4,984
-480
-9% -$38.9K 0.26% 91
2022
Q3
$441K Sell
5,464
-682
-11% -$61.3K 0.37% 76
2022
Q2
$552K Buy
+6,146
New +$623K 0.38% 68
2018
Q3
Sell
-3,460
Closed -$296K 175
2018
Q2
$296K Sell
3,460
-14
-0.4% -$1.17K 0.2% 112
2018
Q1
$279K Sell
3,474
-855
-20% -$70.5K 0.16% 124
2017
Q4
$350K Sell
4,329
-197
-4% -$15.8K 0.22% 119
2017
Q3
$352K Sell
4,526
-2,071
-31% -$172K 0.24% 111
2017
Q2
$586K Sell
6,597
-573
-8% -$48.3K 0.4% 83
2017
Q1
$578K Buy
7,170
+863
+14% +$67.4K 0.43% 81
2016
Q4
$449K Buy
+6,307
New +$495K 0.42% 81

Other funds holding MDT

First Capital Advisors Group's MDT Position: Q2 2023 in Review

First Capital Advisors Group reduced its Medtronic (MDT) stake by 5.6% in Q2 2023, selling an estimated $26.1K and leaving 5,110 shares worth $450K. The position accounts for 0.24% of the portfolio, ranked #79.

First Capital Advisors Group first reported a position in MDT in Q4 2016 and has held it in 12 quarters since. The position peaked at $586K in Q2 2017. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • First Capital Advisors Group held 5,110 shares of Medtronic worth $450K as of Q2 2023.
  • First Capital Advisors Group sold 303 Medtronic shares in Q2 2023, an estimated $26.1K.
  • Medtronic made up 0.24% of First Capital Advisors Group's portfolio in Q2 2023, its #79 holding.
  • First Capital Advisors Group first reported a position in Medtronic in Q4 2016 and has held it in 12 quarters since.
  • First Capital Advisors Group's Medtronic position peaked at $586K in Q2 2017.
  • 2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.